-+ 0.00%
-+ 0.00%
-+ 0.00%

Protagenic Therapeutics exec chair Garo H. Armen acquires 26,291 common shares worth $4,805.99

PUBT·08/03/2026 21:30:06
Listen to the news
Protagenic Therapeutics exec chair Garo H. Armen acquires 26,291 common shares worth $4,805.99
  • Protagenic Therapeutics Executive Chair and Principal Officer Garo H. Armen bought 26,291 common shares in an open-market purchase.
  • Purchase price was $0.18 per share.
  • Armen reported direct ownership of 26,291 common shares following the transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagenic Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-035868), on August 03, 2026, and is solely responsible for the information contained therein.